SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
New Arsenic Nanoparticle Blocks Aggressive Breast Cancer, Northwestern University Study
July 16, 2010
 · 
1 min read
Drug Development
Scientists Create ‘Malaria-Proof’ Mosquito, University of Arizona Reveals
July 16, 2010
 · 
1 min read
Drug Development
Two-Step Vaccine May Offer ‘Universal’ Flu Jab, National Institute of Allergy And Infectious Diseases (NIAID) Study
July 16, 2010
 · 
1 min read
Drug Development
Johns Hopkins University Study: Blind Mice Can ‘See’ Thanks to Special Retinal Cells
July 15, 2010
 · 
3 min read
Drug Development
Artificial Lung “Breathes” In Rats: Massachusetts General Hospital and Harvard Medical School Study
July 14, 2010
 · 
1 min read
Drug Development
A High Fat Diet Alters Crucial Aspects Of Brain Dopamine Signaling, University of Illinois Study
July 14, 2010
 · 
1 min read
Drug Development
Prostate Cancer Risk Located In ‘Gene Desert’, University of Chicago Finds
July 13, 2010
 · 
1 min read
Drug Development
Mice Essentially ‘Cured’ of Mild Diabetes With Enzyme, Oregon State University Study
July 13, 2010
 · 
1 min read
Drug Development
Experimental Obesity Drug Avoids Brain Effects That Troubled Predecessors
July 12, 2010
 · 
1 min read
Drug Development
Protein That Predicts Prognosis Of Leukemia Patients May Also Be A Therapeutic Target, Whitehead Institute and Children’s Hospital Boston Reveals
July 12, 2010
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Data Showing MyMD Pharmaceuticals’ MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological Sciences
August 3, 2022
 · 
7 min read
Drug Development
APIE Therapeutics Presented Preclinical Findings Supporting Activation of the Apelin Receptor as a Therapeutic Approach for Systemic Sclerosis APIE Selected for Oral Presentation at the International Workshop of Scleroderma Research
August 2, 2022
 · 
3 min read
Drug Development
Ashvattha Therapeutics Announces Preclinical Data at the 2022 AAIC Demonstrating its Hydroxyl Dendrimer-Based Imaging Agent [18F]OP-801 Can Detect Early-Stage Neuroinflammation with a Higher Sensitivity Than TSPO-PET
August 1, 2022
 · 
4 min read
Drug Development
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
July 31, 2022
 · 
12 min read
Drug Development
Umoja Biopharma Presents New Preclinical Data at the 2022 iPSC Manufacturing Summit on Synthetic Receptor Enabled Differentiation
July 28, 2022
 · 
5 min read
Drug Development
Akari Therapeutics Announces Positive Results from Recent Pre-Clinical Studies of Investigational PASylated® Nomacopan That Support the Potential to Advance Research Toward IND/IMPD for Clinical Trials in Geographic Atrophy
July 28, 2022
 · 
10 min read
Drug Development
AKSO Announces Publication of Preclinical Data Demonstrating Engineered Soluble BCMA Decoy Receptor AB001 Effectively Inhibits Multiple Myeloma and Diffuse Large B Cell Lymphoma
July 27, 2022
 · 
3 min read
Drug Development
IDEAYA Announces IDE397 Clinical Program Update and ctDNA Molecular Responses Demonstrating Tumor Pharmacodynamic Modulation
July 27, 2022
 · 
6 min read
Drug Development
Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models
July 26, 2022
 · 
3 min read
Drug Development
Humacyte Preclinical Data on Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary Artery Bypass Grafting (CABG) Presented at American Heart Association Meeting
July 25, 2022
 · 
8 min read
Business
IAMA Therapeutics Announces Initiation of Preclinical Development Studies in Drug-resistant Epilepsy Under a Service Agreement with Psychogenics
July 25, 2022
 · 
3 min read
Drug Development
Preclinical Data Demonstrate Potential of Creative Bio-Peptides’ Multi-Chemokine Receptor Antagonist RAP-103 to Enhance Opioid Analgesia and Inhibit Opioid-derived Dependence, Withdrawal and Respiratory Depression
July 19, 2022
 · 
4 min read
Drug Development
Humacyte Announces Presentation of Preclinical Data on the HAV™ in Coronary Artery Bypass Grafting at the Basic Cardiovascular Sciences Scientific Sessions
July 19, 2022
 · 
2 min read
Business
Tectonic Therapeutic Strengthens Leadership Team
July 19, 2022
 · 
4 min read
Drug Development
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based PET Tracer [18F]OP-801 at the 2022 Alzheimer’s Association International Conference (AAIC)
July 18, 2022
 · 
3 min read
Drug Development
Preclinical Data Demonstrate Potential of Creative Bio-Peptides’ Multi-Chemokine Receptor Antagonist RAP-103 to Provide Opioid Sparing Post-Surgical Pain Relief and Treatment for Chronic Pain
July 14, 2022
 · 
5 min read
Drug Development
Comera Life Sciences Announces Favorable Preclinical Topline Safety Results of Lead SQore Excipient
July 13, 2022
 · 
6 min read
Drug Development
Nuvalent to Present New NVL-655 Preclinical Data and ARROS-1 Trial in Progress Poster for NVL-520 at IASLC 2022 World Conference on Lung Cancer Annual Meeting
July 13, 2022
 · 
8 min read
Drug Development
Histopathology Data of Preclinical Repeated Dose Toxicity Study and ex vivo Human Tissue Cross-Reactivity (TCR) Analysis Support Safety of IPA’s PolyTope® TATX-03, a Synergistic Antibody Cocktail against SARS‑CoV‑2
July 12, 2022
 · 
6 min read
Drug Development
Coagulant Therapeutics Presents Data for Severe Postpartum Hemorrhage Clinical Candidate, CT-001, at International Society for Thrombosis and Haemostasis Congress
July 12, 2022
 · 
4 min read
Load More